CRISPR/ Cas9: A Toolbox with Clinical Potential-Juniper Publishers

The CRISPR/ Cas9 machinery, which is known to provide adaptive immunity to bacteria and archeae, has been proven an efficient tool for genome editing in a wide range of organisms. It is an RNA-guided DNA endonuclease that introduces double-stranded breaks in the target DNA. This compact machinery has been adapted and is being widely used for precise editing and modification of the genome [1]. This review focuses on genome editing using the CRISPR/ Cas9 system for correction of genetic diseases. Here, we review examples from literature where the CRISPR/ Cas9 system has been used for the correction of Duchenne Muscular Dystrophy (DMD), cataract caused due to mutations in the Crygc gene, cystic fibrosis, and sickle cell disease.

For more Open access journals please click on https://juniperpublishers.com/
For more articles please click on https://juniperpublishers.com/ijcsmb/index.php

Comments

Popular posts from this blog

Hypothesis Nature has provided the two Subsets required for Translational Lung Cancer Research-Juniper Publishers

Lipomatosis in a Developing Communitys-Juniper Publishers

Nasopharyngeal Lymphoma in a developing Community- juniper Publishers